Meeting of the Advisory Council on Blood Stem Cell Transplantation, 55466 [2020-19690]
Download as PDF
<![CDATA[
55466
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
STAR LRP Application .........................................................
Authorization for Disclosure of Loan Information Form .......
Privacy Act Release Authorization Form .............................
Employment Verification Form .............................................
Site Application ....................................................................
300
300
300
300
400
1
1
1
1
1
300
300
300
300
400
.50
.50
.50
.50
1.00
150
150
150
150
400
Total ..............................................................................
1,600
........................
1,600
........................
1000
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–19776 Filed 9–4–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Council on
Blood Stem Cell Transplantation
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
Advisory Council on Blood Stem Cell
Transplantation (ACBSCT) has
scheduled a public meeting. Information
about ACBSCT and the agenda for this
meeting can be found on the ACBSCT
website at https://
bloodstemcell.hrsa.gov/about/advisorycouncil.
DATES: September 25, 2020, from 12:00
p.m.–6:00 p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held
by webinar and conference call. The
webinar link, conference call-in
number, registration information, and
SUMMARY:
jbell on DSKJLSW7X2PROD with NOTICES
Number of
responses per
respondent
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
meeting materials can be accessed
through the registration link on the
ACBSCT website at https://
bloodstemcell.hrsa.gov/about/advisorycouncil.
FOR FURTHER INFORMATION CONTACT:
Robert Walsh, Designated Federal
Official, (DFO), at Division of
Transplantation, HRSA, 5600 Fishers
Lane, Rockville, Maryland 20857; 301–
443–6839; or ACBSCTHRSA@hrsa.gov.
SUPPLEMENTARY INFORMATION: ACBSCT
provides advice and recommendations
to the Secretary of HHS (Secretary) and
the HRSA Administrator on the
activities of the C.W. Bill Young Cell
Transplantation Program (CWBYCTP)
and the National Cord Blood Inventory
(NCBI) Program. The principal purpose
of these programs is to make blood stem
cells from adult donors and cord blood
units available for patients who need a
transplant to treat life-threatening
conditions such as leukemia, and who
lack a suitably matched relative who
can be the donor.
During the September 25, 2020,
meeting, the ACBSCT will receive
updates on the operation of the
CWBYCTP and the NCBI and discuss
cord blood as a continued source of
blood stem cells for transplant in the
context of other available sources of
blood stem cells for transplant. Agenda
items are subject to change as priorities
dictate. Refer to the ACBSCT website for
any updated information concerning the
meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to ACBSCT
should be sent to Robert Walsh, DFO,
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
using the contact information above at
least three business days prior to the
meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Robert Walsh at the address and
phone number listed above at least 10
business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–19690 Filed 9–4–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the President’s Council on
Sports, Fitness, and Nutrition
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice of meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS) is hereby giving notice
that the President’s Council on Sports,
Fitness & Nutrition (PCSFN) will hold
its annual meeting. The meeting will be
open to the public.
DATES: The meeting will take place on
Thursday, September 17, 2020, from
1:00 p.m. to 5:00 p.m. (EDT).
ADDRESSES: The meeting will be held
virtually using an online platform. To
register to attend the meeting, please
visit the registration website at https://
kauffmaninc.adobeconnect.com/ch_
pcsfn_sept2020/event/event_info.html.
FOR FURTHER INFORMATION CONTACT:
Jennifer Anne Bishop, Sc.D., M.P.H.,
Designated Federal Officer for the
PCSFN, 1101 Wootton Parkway, Suite
SUMMARY:
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 85, Number 174 (Tuesday, September 8, 2020)]
[Notices]
[Page 55466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19690]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Council on Blood Stem Cell
Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Advisory Council on Blood Stem
Cell Transplantation (ACBSCT) has scheduled a public meeting.
Information about ACBSCT and the agenda for this meeting can be found
on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.
DATES: September 25, 2020, from 12:00 p.m.-6:00 p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held by webinar and conference call.
The webinar link, conference call-in number, registration information,
and meeting materials can be accessed through the registration link on
the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.
FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal
Official, (DFO), at Division of Transplantation, HRSA, 5600 Fishers
Lane, Rockville, Maryland 20857; 301-443-6839; or [email protected].
SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations
to the Secretary of HHS (Secretary) and the HRSA Administrator on the
activities of the C.W. Bill Young Cell Transplantation Program
(CWBYCTP) and the National Cord Blood Inventory (NCBI) Program. The
principal purpose of these programs is to make blood stem cells from
adult donors and cord blood units available for patients who need a
transplant to treat life-threatening conditions such as leukemia, and
who lack a suitably matched relative who can be the donor.
During the September 25, 2020, meeting, the ACBSCT will receive
updates on the operation of the CWBYCTP and the NCBI and discuss cord
blood as a continued source of blood stem cells for transplant in the
context of other available sources of blood stem cells for transplant.
Agenda items are subject to change as priorities dictate. Refer to the
ACBSCT website for any updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to ACBSCT should be
sent to Robert Walsh, DFO, using the contact information above at least
three business days prior to the meeting.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Robert Walsh at the
address and phone number listed above at least 10 business days prior
to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-19690 Filed 9-4-20; 8:45 am]
BILLING CODE 4165-15-P
